Bisma Rauff

1.0k total citations
21 papers, 670 citations indexed

About

Bisma Rauff is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Bisma Rauff has authored 21 papers receiving a total of 670 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 11 papers in Hepatology and 6 papers in Molecular Biology. Recurrent topics in Bisma Rauff's work include Hepatitis C virus research (10 papers), Liver Disease Diagnosis and Treatment (8 papers) and Hepatitis B Virus Studies (5 papers). Bisma Rauff is often cited by papers focused on Hepatitis C virus research (10 papers), Liver Disease Diagnosis and Treatment (8 papers) and Hepatitis B Virus Studies (5 papers). Bisma Rauff collaborates with scholars based in Pakistan, Saudi Arabia and Australia. Bisma Rauff's co-authors include Shafquat Rafiq, Meryem Jefferies, Harunor Rashid, Thao Minh Lam, Sadia Butt, Muhammad Idrees, Liaqat Ali, Abrar Hussain, Sana Saleem and Azeem Mehmood Butt and has published in prestigious journals such as PLoS ONE, Scientific Reports and Current Pharmaceutical Design.

In The Last Decade

Bisma Rauff

20 papers receiving 642 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bisma Rauff Pakistan 9 326 319 160 108 83 21 670
Celso Spada Brazil 16 271 0.8× 348 1.1× 174 1.1× 27 0.3× 39 0.5× 39 653
Arício Treitinger Brazil 15 229 0.7× 338 1.1× 136 0.8× 26 0.2× 27 0.3× 32 532
Lili Yuan China 16 79 0.2× 150 0.5× 107 0.7× 281 2.6× 151 1.8× 56 736
Juliana Gil Melgaço Brazil 12 292 0.9× 266 0.8× 196 1.2× 40 0.4× 119 1.4× 28 659
Catherine Maidens United Kingdom 10 626 1.9× 464 1.5× 71 0.4× 74 0.7× 211 2.5× 11 932
Juliane Doerrbecker Germany 14 302 0.9× 313 1.0× 126 0.8× 41 0.4× 39 0.5× 17 545
Makie Taal Gambia 13 479 1.5× 509 1.6× 74 0.5× 196 1.8× 23 0.3× 18 822
Justin Chan United States 14 121 0.4× 194 0.6× 146 0.9× 48 0.4× 176 2.1× 34 640
Maria Beatrice Valli Italy 18 211 0.6× 315 1.0× 114 0.7× 22 0.2× 149 1.8× 38 597
Maria Elisabetta Rossi Italy 16 170 0.5× 277 0.9× 75 0.5× 22 0.2× 35 0.4× 39 677

Countries citing papers authored by Bisma Rauff

Since Specialization
Citations

This map shows the geographic impact of Bisma Rauff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bisma Rauff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bisma Rauff more than expected).

Fields of papers citing papers by Bisma Rauff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bisma Rauff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bisma Rauff. The network helps show where Bisma Rauff may publish in the future.

Co-authorship network of co-authors of Bisma Rauff

This figure shows the co-authorship network connecting the top 25 collaborators of Bisma Rauff. A scholar is included among the top collaborators of Bisma Rauff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bisma Rauff. Bisma Rauff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Naz, Anam, et al.. (2025). Comprehensive immunoinformatics and structural biology based design for novel peptide vaccines against Epstein-Barr virus. Gene Reports. 38. 102137–102137. 1 indexed citations
3.
Malik, Shiza, et al.. (2023). Cytotoxicity Study of Gold Nanoparticle Synthesis Using Aloe vera, Honey, and Gymnema sylvestre Leaf Extract. ACS Omega. 8(7). 6325–6336. 31 indexed citations
4.
Awan, Faryal Mehwish, Bisma Rauff, Badr Alzahrani, et al.. (2023). Mapping CircRNA–miRNA–mRNA regulatory axis identifies hsa_circ_0080942 and hsa_circ_0080135 as a potential theranostic agents for SARS-CoV-2 infection. PLoS ONE. 18(4). e0283589–e0283589. 7 indexed citations
5.
Rauff, Bisma, Badr Alzahrani, Bilal Nasir, et al.. (2022). PNPLA3 and TM6SF2 genetic variants and hepatic fibrosis and cirrhosis in Pakistani chronic hepatitis C patients: a genetic association study. BMC Gastroenterology. 22(1). 401–401. 3 indexed citations
6.
Ikram, Aqsa, Bisma Rauff, Badr Alzahrani, et al.. (2022). Integrated analysis to study the interplay between post-translational modifications (PTM) in hepatitis C virus proteins and hepatocellular carcinoma (HCC) development. Scientific Reports. 12(1). 15648–15648. 4 indexed citations
7.
Akhtar, Hashaam, et al.. (2022). A Case Report of Dengue Shock Syndrome Complicated with Multi-Organ Failure and Hepatitis E Virus Superinfection. Future Virology. 17(10). 717–721. 2 indexed citations
8.
Baloch, Zulqarnain, Aqsa Ikram, Saba Shamim, et al.. (2022). Human Coronavirus Spike Protein Based Multi-Epitope Vaccine against COVID-19 and Potential Future Zoonotic Coronaviruses by Using Immunoinformatic Approaches. Vaccines. 10(7). 1150–1150. 3 indexed citations
9.
Rauff, Bisma, et al.. (2021). Interferon-λ rs12979860 genotype association with liver fibrosis in chronic hepatitis C (CHC) patients in the Pakistani population. Archives of Virology. 166(4). 1047–1056. 2 indexed citations
10.
Malik, Arif, Anam Naz, Sajjad Ahmad, et al.. (2021). Inhibitory Potential of Phytochemicals on Interleukin-6-Mediated T-Cell Reduction in COVID-19 Patients: A Computational Approach. Bioinformatics and Biology Insights. 15. 739586678–739586678. 16 indexed citations
11.
Rauff, Bisma, et al.. (2020). Notch signalling pathway in development of cholangiocarcinoma. World Journal of Gastrointestinal Oncology. 12(9). 957–974. 13 indexed citations
12.
Jefferies, Meryem, Bisma Rauff, Harunor Rashid, Thao Minh Lam, & Shafquat Rafiq. (2018). Update on global epidemiology of viral hepatitis and preventive strategies. World Journal of Clinical Cases. 6(13). 589–599. 214 indexed citations
13.
Mathew, Shilu, et al.. (2016). Hepatitis C virus and neurological damage. World Journal of Hepatology. 8(12). 545–545. 51 indexed citations
14.
Khubaib, Bushra, Muhammad Idrees, Abrar Hussain, et al.. (2012). Association of Hepatitis C Virus With Insulin Resistance: Evidences From Animal Studies and Clinical Studie. Hepatitis Monthly. 12(1). 11–15. 3 indexed citations
15.
Khubaib, Bushra, Muhammad Idrees, Abrar Hussain, et al.. (2012). Association of Hepatitis C Virus With Insulin Resistance: Evidences From Animal Studies and Clinical Studies. Hepatitis Monthly. 12(1). 11–15. 5 indexed citations
16.
Rauff, Bisma, Muhammad Idrees, Sadia Butt, et al.. (2011). Hepatitis Associated Aplastic Anemia: A review. Virology Journal. 8(1). 87–87. 106 indexed citations
17.
Fatima, Zareen, Muhammad Idrees, Zarfishan Tahir, et al.. (2011). Serotype and genotype analysis of dengue virus by sequencing followed by phylogenetic analysis using samples from three mini outbreaks-2007-2009 in Pakistan. BMC Microbiology. 11(1). 200–200. 84 indexed citations
18.
Idrees, Muhammad, Zunaira Awan, Shazia Rafique, et al.. (2010). Hepatitis B virus YMDD-motif mutations with emergence of lamivudine-resistant mutants: a threat to recovery. 3(3). 5 indexed citations
19.
Awan, Zunaira, Muhammad Idrees, Irum Amin, et al.. (2010). Pattern and molecular epidemiology of Hepatitis B virus genotypes circulating in Pakistan. Infection Genetics and Evolution. 10(8). 1242–1246. 28 indexed citations
20.
Saleem, Sana, Muhammad Idrees, Sadia Butt, et al.. (2010). Hepatitis C Treatment: current and future perspectives. Virology Journal. 7(1). 296–296. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026